3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
Nutrition Assessment
3
Metformin
3
Tablets
2
Resistance Training
2
Pioglitazone
2
Methods
2
Exercise
2
Educational Status
2
otelixizumab
1
nabiximols
1
Verapamil
1
Therapeutics
1
Surveys and Questionnaires
1
Specimen Handling
1
Risk Assessment
1
Remote Consultation
1
Pancreas, Artificial
1
Palliative Care
1
Lysine Acetyltransferase 5
1
Jogging
1
Interviews as Topic
1
Gastrectomy
1
Fish Oils
1
Endoscopic Mucosal Resection
1
Eating
1
Docosahexaenoic Acids
1
Diet, Mediterranean
1
Diet, Fat-Restricted
1
Diet, Carbohydrate-Restricted
1
DM199
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Diabetes Mellitus
×
Therapeutics
×
Clear all
NCT03443635
2022-04-29
CHOP
Tulane University
Phase 1/2
Completed
7,192 enrolled
7 charts